Fremont, California -- Biomerix Corp. and Cellon SA have signed a distribution agreement under which Cellon will market and distribute the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold, to research institutions across Europe.
The Biomerix 3D Scaffold is a non-degradable, three-dimensional, open-cell polycarbonate polyurethane, and is designed, said the company, "to mimic the nature and function of the extracellular matrix (ECM)."
The material's "novel macroporous microarchitecture consists of a network of interconnecting cells and pores." According the Biomrerix, this creates "an environment highly conducive to applications in regenerative medicine, drug discovery, and stem cell research."
Noting that the partnership strengthens each company's European presence in regenerative medicine, tissue engineering, and in drug discovery, development and delivery, Kenneth Hayes, president and ceo of Biomerix, said the biomaterial used in the scaffold has ???seven US and international regulatory clearances for different indications in soft tissue repair, orthopedics, and vascular embolisation."
According to the company, the unique chemistry and microarchitecture of the 3D Scaffold has been shown to support optimal cell proliferation and superior cell viability in both in-vitro and in-vivo studies involving diverse cell types.
"
